With a surging demand for GLP-1 medical weight loss drugs, many medical spas are eager to incorporate this service as an exciting growth and revenue opportunity. However, the ever-changing regulatory landscape around these drugs can leave business owners with more questions than answers.
In this session, Julia Cantu deliver's the most up-to-date legal information on adding a medical weight loss program to your practice.
Julia will cover:
- FDA Status on Semaglutide and Tirzepatide
- Is compounding GLP-1s legal? Considerations and variations by state law.
- How to read the FDA shortage list
- Responding to legal notice from Eli Lilly
- Navigating the future on weight loss drugs and regulation
- How to protect your med spa or practice
Equip your business with the knowledge to navigate regulatory challenges and protect your practice while tapping into this growing market.
Get the most from your show experience by taking a conference class and expanding your professional knowledge. Add this class to your cart during registration. REGISTER TODAY!
